- Home
- IBIO vs OXBR Comparison
IBIO vs OXBR Comparison
Compare IBIO & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- OXBR
- Stock Information
- Founded
- IBIO 2008
- OXBR 2013
- Country
- IBIO United States
- OXBR Cayman Islands
- Employees
- IBIO N/A
- OXBR N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- OXBR Property-Casualty Insurers
- Sector
- IBIO Health Care
- OXBR Finance
- Exchange
- IBIO Nasdaq
- OXBR Nasdaq
- Market Cap
- IBIO 16.4M
- OXBR 13.7M
- IPO Year
- IBIO N/A
- OXBR 2014
- Fundamental
- Price
- IBIO $1.54
- OXBR $1.63
- Analyst Decision
- IBIO Strong Buy
- OXBR Strong Buy
- Analyst Count
- IBIO 4
- OXBR 1
- Target Price
- IBIO $4.50
- OXBR $5.00
- AVG Volume (30 Days)
- IBIO 7.2M
- OXBR 26.8K
- Earning Date
- IBIO 10-31-2025
- OXBR 11-06-2025
- Dividend Yield
- IBIO N/A
- OXBR N/A
- EPS Growth
- IBIO N/A
- OXBR N/A
- EPS
- IBIO N/A
- OXBR N/A
- Revenue
- IBIO $400,000.00
- OXBR $1,983,000.00
- Revenue This Year
- IBIO N/A
- OXBR $497.99
- Revenue Next Year
- IBIO N/A
- OXBR $42.14
- P/E Ratio
- IBIO N/A
- OXBR N/A
- Revenue Growth
- IBIO 77.78
- OXBR N/A
- 52 Week Low
- IBIO $0.56
- OXBR $1.27
- 52 Week High
- IBIO $6.89
- OXBR $5.81
- Technical
- Relative Strength Index (RSI)
- IBIO 77.05
- OXBR 40.68
- Support Level
- IBIO $1.02
- OXBR $1.51
- Resistance Level
- IBIO $1.72
- OXBR $1.75
- Average True Range (ATR)
- IBIO 0.19
- OXBR 0.11
- MACD
- IBIO 0.06
- OXBR -0.01
- Stochastic Oscillator
- IBIO 80.82
- OXBR 33.32
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.